FDA approves Nexium for treatment of teens
The FDA this week cleared AstraZeneca to market its heartburn treatment Nexium to children ages 12 through 17 for the ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.